Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer

Shigeki Umemura, Yoshihiko Segawa, Hiroshi Ueoka, Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa, Masahiro Tabata, Akihiro Bessho, Tetsu Shinkai, Mitsune Tanimoto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: The purpose of this study is to elucidate the influence of serum arginine-vasopressin (AVP) level on prognosis of extensive-disease small-cell lung cancer (ED-SCLC). Methods: We retrospectively investigated the clinical records of 163 patients with ED-SCLC, who were admitted to Okayama University Hospital or National Shikoku Cancer Center Hospital. The influence of 14 pretreatment variables on survival was analyzed. Results: In a multivariate analysis of 163 patients, elevation of serum LDH level (P = 0.028) and poor performance status (PS ≥ 2, P = 0.002) were independent poor prognostic factors. In 34 patients whose serum AVP levels were available, high serum AVP level was related to the poor prognosis (P <0.001). The serum-sodium level did not affect the survival. Median serum level of osmotic pressure in 34 patients was normal (284.9 mOsm/kg), although, serum osmotic pressure was low in four of six patients with high serum AVP level. In all patients with high serum AVP level, serum LDH level was elevated. Conclusions: The data from the current study suggested that serum LDH level and PS were the poor prognostic factors for ED-SCLC. But we additionally identified the prognostic significance of serum AVP level, which may be a more useful factor than serum-sodium level.

Original languageEnglish
Pages (from-to)519-524
Number of pages6
JournalJournal of Cancer Research and Clinical Oncology
Volume133
Issue number8
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Arginine Vasopressin
Small Cell Lung Carcinoma
Serum
Osmotic Pressure
Sodium
Cancer Care Facilities
Survival
Multivariate Analysis

Keywords

  • Arginin-vasopressin (AVP)
  • Osmotic pressure
  • Prognostic factor
  • Small-cell lung cancer
  • Sodium

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer. / Umemura, Shigeki; Segawa, Yoshihiko; Ueoka, Hiroshi; Hotta, Katsuyuki; Kiura, Katsuyuki; Takigawa, Nagio; Tabata, Masahiro; Bessho, Akihiro; Shinkai, Tetsu; Tanimoto, Mitsune.

In: Journal of Cancer Research and Clinical Oncology, Vol. 133, No. 8, 08.2007, p. 519-524.

Research output: Contribution to journalArticle

Umemura, Shigeki ; Segawa, Yoshihiko ; Ueoka, Hiroshi ; Hotta, Katsuyuki ; Kiura, Katsuyuki ; Takigawa, Nagio ; Tabata, Masahiro ; Bessho, Akihiro ; Shinkai, Tetsu ; Tanimoto, Mitsune. / Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer. In: Journal of Cancer Research and Clinical Oncology. 2007 ; Vol. 133, No. 8. pp. 519-524.
@article{f8856c0fac21481ba945c1f69126af5a,
title = "Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer",
abstract = "Purpose: The purpose of this study is to elucidate the influence of serum arginine-vasopressin (AVP) level on prognosis of extensive-disease small-cell lung cancer (ED-SCLC). Methods: We retrospectively investigated the clinical records of 163 patients with ED-SCLC, who were admitted to Okayama University Hospital or National Shikoku Cancer Center Hospital. The influence of 14 pretreatment variables on survival was analyzed. Results: In a multivariate analysis of 163 patients, elevation of serum LDH level (P = 0.028) and poor performance status (PS ≥ 2, P = 0.002) were independent poor prognostic factors. In 34 patients whose serum AVP levels were available, high serum AVP level was related to the poor prognosis (P <0.001). The serum-sodium level did not affect the survival. Median serum level of osmotic pressure in 34 patients was normal (284.9 mOsm/kg), although, serum osmotic pressure was low in four of six patients with high serum AVP level. In all patients with high serum AVP level, serum LDH level was elevated. Conclusions: The data from the current study suggested that serum LDH level and PS were the poor prognostic factors for ED-SCLC. But we additionally identified the prognostic significance of serum AVP level, which may be a more useful factor than serum-sodium level.",
keywords = "Arginin-vasopressin (AVP), Osmotic pressure, Prognostic factor, Small-cell lung cancer, Sodium",
author = "Shigeki Umemura and Yoshihiko Segawa and Hiroshi Ueoka and Katsuyuki Hotta and Katsuyuki Kiura and Nagio Takigawa and Masahiro Tabata and Akihiro Bessho and Tetsu Shinkai and Mitsune Tanimoto",
year = "2007",
month = "8",
doi = "10.1007/s00432-007-0196-y",
language = "English",
volume = "133",
pages = "519--524",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer

AU - Umemura, Shigeki

AU - Segawa, Yoshihiko

AU - Ueoka, Hiroshi

AU - Hotta, Katsuyuki

AU - Kiura, Katsuyuki

AU - Takigawa, Nagio

AU - Tabata, Masahiro

AU - Bessho, Akihiro

AU - Shinkai, Tetsu

AU - Tanimoto, Mitsune

PY - 2007/8

Y1 - 2007/8

N2 - Purpose: The purpose of this study is to elucidate the influence of serum arginine-vasopressin (AVP) level on prognosis of extensive-disease small-cell lung cancer (ED-SCLC). Methods: We retrospectively investigated the clinical records of 163 patients with ED-SCLC, who were admitted to Okayama University Hospital or National Shikoku Cancer Center Hospital. The influence of 14 pretreatment variables on survival was analyzed. Results: In a multivariate analysis of 163 patients, elevation of serum LDH level (P = 0.028) and poor performance status (PS ≥ 2, P = 0.002) were independent poor prognostic factors. In 34 patients whose serum AVP levels were available, high serum AVP level was related to the poor prognosis (P <0.001). The serum-sodium level did not affect the survival. Median serum level of osmotic pressure in 34 patients was normal (284.9 mOsm/kg), although, serum osmotic pressure was low in four of six patients with high serum AVP level. In all patients with high serum AVP level, serum LDH level was elevated. Conclusions: The data from the current study suggested that serum LDH level and PS were the poor prognostic factors for ED-SCLC. But we additionally identified the prognostic significance of serum AVP level, which may be a more useful factor than serum-sodium level.

AB - Purpose: The purpose of this study is to elucidate the influence of serum arginine-vasopressin (AVP) level on prognosis of extensive-disease small-cell lung cancer (ED-SCLC). Methods: We retrospectively investigated the clinical records of 163 patients with ED-SCLC, who were admitted to Okayama University Hospital or National Shikoku Cancer Center Hospital. The influence of 14 pretreatment variables on survival was analyzed. Results: In a multivariate analysis of 163 patients, elevation of serum LDH level (P = 0.028) and poor performance status (PS ≥ 2, P = 0.002) were independent poor prognostic factors. In 34 patients whose serum AVP levels were available, high serum AVP level was related to the poor prognosis (P <0.001). The serum-sodium level did not affect the survival. Median serum level of osmotic pressure in 34 patients was normal (284.9 mOsm/kg), although, serum osmotic pressure was low in four of six patients with high serum AVP level. In all patients with high serum AVP level, serum LDH level was elevated. Conclusions: The data from the current study suggested that serum LDH level and PS were the poor prognostic factors for ED-SCLC. But we additionally identified the prognostic significance of serum AVP level, which may be a more useful factor than serum-sodium level.

KW - Arginin-vasopressin (AVP)

KW - Osmotic pressure

KW - Prognostic factor

KW - Small-cell lung cancer

KW - Sodium

UR - http://www.scopus.com/inward/record.url?scp=34250706842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250706842&partnerID=8YFLogxK

U2 - 10.1007/s00432-007-0196-y

DO - 10.1007/s00432-007-0196-y

M3 - Article

VL - 133

SP - 519

EP - 524

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 8

ER -